ProCE Banner Events

Share

Contemporary Management of PV: Data Review and Case Challenges Illustrating Current Best Practice

Register now for this CME/CNE/CPE/AAPA-certified interactive workshop series for community hematologists/oncologists and other multidisciplinary team members on up-to-date treatment strategies for patients with polycythemia vera (PV)! After the meeting, download the associated slideset and read an expert commentary answering questions from the community.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Registration not open

Credits Available

1.0

Who Should Attend

This program is intended for community-based medical hematologists/oncologists, advanced practice providers, nurses, pharmacists and other healthcare professionals involved in the treatment of patients with polycythemia vera.

Time and location

Friday, December 15, 2023

8:30 AM - 9:30 AM Mountain Time (MT)

Virtual

Virtual Event | Host Group in NM
Albuquerque, New Mexico

Faculty
Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of South Florida
Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Agenda

  • State-of-the-art diagnosis, classification, and molecular prognostication of PV
  • Fine-tuning PV treatment: upfront and refractory to initial cytoreductive therapy
  • Consensus guideline‒preferred regimens for PV refractory to initial therapy
  • Special considerations in the treatment of PV
  • Investigational strategies on the horizon

Location

Venue Name

Virtual Event | Host Group in NM

Address

Virtual Event | Host Group in NM
Albuquerque, New Mexico

CME/CE Info

Goal
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Myeloproliferative neoplasms (MPN)

Target Audience
This program is intended for community-based medical hematologists/oncologists, advanced practice providers, nurses, pharmacists and other healthcare professionals involved in the treatment of patients with polycythemia vera. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify factors used to stratify risk and initiate cytoreductive therapy in PV, including potentially disease-modifying therapies in low-risk PV
  • Recognize symptoms and patterns of first-line treatment failure in patients with MPNs, including treatment intolerance and treatment resistance
  • Institute best practices for transitioning to a clinically appropriate second-line therapy after first-line treatment failure for patients with PV
  • Integrate supportive care plans into practice that are designed to monitor symptoms and manage treatment-related toxicities from current and emerging PV treatments
  • Review data on emerging novel targets and mechanisms that have the potential to change clinical practice in PV and ET

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-142-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate/Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from Incyte Corporation and PharmaEssentia USA Corporation.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.